🇺🇸 FDA
Patent

US 7960535

Recombinant lipidated PsaA protein, methods of preparation and use

granted A61KA61K39/00A61P

Quick answer

US patent 7960535 (Recombinant lipidated PsaA protein, methods of preparation and use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K39/00, A61P, A61P31/04